|
| Age (y) | Sex | Bladder cancer stage/type | Number of BCG therapy sessions | Side effect | Antituberculosis drug | Steroid pulse therapy (type, dose; duration) | Outcome |
|
| Case 1 | 60 | Female | pTa high-grade | 4 | Fever, knee joint pain, conjunctival hyperemia | INH, 300 mg/day; REP, 450 mg/day; EB, 750 mg/day | Methylprednisolone, 1000 mg/day; 3 days (1 course) | Alive |
| Case 2 | 66 | Female | CIS | 8 | Knee joint pain, conjunctival hyperemia, urethritis | None | Methylprednisolone, 1000 mg/day; 3 days (1 course) | Alive |
| Case 3 | 76 | Male | pTa high-grade | 4 | Fever, knee and elbow joint pain, conjunctival hyperemia | None | Methylprednisolone, 500 mg/day; 3 days (1 course) | Alive |
| Case 4 | 77 | Female | pT1 high-grade | 3 | Fever, knee joint pain, urethritis | None | Methylprednisolone, 1000 mg/day; 3 days (1 course) | Alive |
| Case 5 | 73 | Male | pT1 high-grade | 14 | Fever, impaired consciousness, BCG sepsis | INH, 300 mg/day; REP, 450 mg/day; EB, 750 mg/day | Methylprednisolone, 1000 mg/day; 6 days (2 courses) | Alive |
|
